Is preclinical research in cancer biology reproducible enough?
The Reproducibility Project: Cancer Biology (RPCB) was established to provide evidence about reproducibility in basic and preclinical cancer research, and to identify the factors that influence reproducibility more generally. In this commentary we address some of the scientific, ethical and policy i...
Main Authors: | Patrick Bodilly Kane, Jonathan Kimmelman |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-12-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/67527 |
Similar Items
-
Investigating the replicability of preclinical cancer biology
by: Timothy M Errington, et al.
Published: (2021-12-01) -
An open investigation of the reproducibility of cancer biology research
by: Timothy M Errington, et al.
Published: (2014-12-01) -
Why clinical translation cannot succeed without failure
by: Alex John London, et al.
Published: (2015-11-01) -
Challenges for assessing replicability in preclinical cancer biology
by: Timothy M Errington, et al.
Published: (2021-12-01) -
Improving preclinical studies through replications
by: Natascha Ingrid Drude, et al.
Published: (2021-01-01)